UK markets open in 5 hours 48 minutes
NIKKEI 225
37,297.26 -782.44 (-2.05%) HANG SENG
16,385.87 +134.03 (+0.82%) CRUDE OIL
83.50 +0.77 (+0.93%) GOLD FUTURES
2,395.70 -2.30 (-0.10%) DOW
37,775.38 +22.07 (+0.06%) Bitcoin GBP
50,301.51 +732.00 (+1.48%)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 330.03B |
| Enterprise value | 310.62B |
| Trailing P/E | 29.08 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 9.59 |
| Price/book (mrq) | 8.96 |
| Enterprise value/revenue | 9.04 |
| Enterprise value/EBITDA | 24.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.08 |
| 52-week change 3 | -11.80% |
| S&P500 52-week change 3 | 21.61% |
| 52-week high 3 | 325.00 |
| 52-week low 3 | 253.48 |
| 50-day moving average 3 | 286.88 |
| 200-day moving average 3 | 282.51 |
Share statistics
| Avg vol (3-month) 3 | 3.82M |
| Avg vol (10-day) 3 | 3.7M |
| Shares outstanding 5 | 1.21B |
| Implied shares outstanding 6 | 1.21B |
| Float 8 | 488.65M |
| % held by insiders 1 | 58.01% |
| % held by institutions 1 | 18.68% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 8.8 |
| Forward annual dividend yield 4 | 3.23% |
| Trailing annual dividend rate 3 | 8.80 |
| Trailing annual dividend yield 3 | 3.23% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 48.08% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 22 Nov 2023 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2022 |
| Most-recent quarter (mrq) | 30 Sept 2023 |
Profitability
| Profit margin | 32.99% |
| Operating margin (ttm) | 45.70% |
Management effectiveness
| Return on assets (ttm) | 16.72% |
| Return on equity (ttm) | 33.83% |
Income statement
| Revenue (ttm) | 34.37B |
| Revenue per share (ttm) | 28.40 |
| Quarterly revenue growth (yoy) | 11.20% |
| Gross profit (ttm) | N/A |
| EBITDA | 13.1B |
| Net income avi to common (ttm) | 11.34B |
| Diluted EPS (ttm) | 9.36 |
| Quarterly earnings growth (yoy) | 20.50% |
Balance sheet
| Total cash (mrq) | 19.67B |
| Total cash per share (mrq) | 16.25 |
| Total debt (mrq) | 261.02M |
| Total debt/equity (mrq) | 0.71% |
| Current ratio (mrq) | 2.79 |
| Book value per share (mrq) | 30.42 |
Cash flow statement
| Operating cash flow (ttm) | 13.17B |
| Levered free cash flow (ttm) | 6.4B |
© 2024 Yahoo. All rights reserved.